Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment

Keyphrases

• Single nucleotide Polymorphism 100%
• Polymorphism 100%
• Fracture Risk 100%
• Estrogen Treatment 100%
• P2RX7 Gene 100%
• Hormone Replacement Therapy 50%
• Bone Mineral Density 50%
• Osteocyte Apoptosis 50%
• Postmenopausal Women 33%
• Osteoclast 33%
• Exon 13 33%
• Fracture Incidence 33%
• P2X7 Receptor (P2X7R) 33%
• P2RX7 33%
• Genotype 16%
• Nave 16%
• Osteoclast Activity 16%
• Lumbar Spine 16%
• Vertebral Fracture 16%
• Bone Turnover Markers 16%
• Purinergic 16%
• Osteoblast Functions 16%
• Apoptotic Activity 16%
• Caspase-1 16%
• Bone Status 16%
• Mineral Transformation 16%
• Therapy Treatment 16%
• Hip-spine 16%
• 10-year Fracture Probability 16%

Immunology and Microbiology

• Single Nucleotide Polymorphism 100%
• Osteoclast 100%
• In Vitro 80%
• Bone Density 60%
• Programmed Cell Death 60%
• Exon 40%
• Postmenopause 40%
• Hip 20%
• Allele 20%
• Osteoblast 20%
• Osteoclast Activity 20%
• Caspase 1 20%
• Lumbar Spine 20%

Biochemistry, Genetics and Molecular Biology

• Single-Nucleotide Polymorphism 100%
• Osteoclast 100%
• Bone Density 60%
• Programmed Cell Death 60%
• Adenosine Triphosphate 40%
• Postmenopause 40%
• Exon 40%
• P2RX7 40%
• Osteoblast 20%
• Allele 20%
• Osteoclast Activity 20%
• Caspase 1 20%